The expanding role of pyridine and dihydropyridine scaffolds in drug design

Y Ling, ZY Hao, D Liang, CL Zhang… - Drug design …, 2021 - Taylor & Francis
Pyridine-based ring systems are one of the most extensively used heterocycles in the field of
drug design, primarily due to their profound effect on pharmacological activity, which has led …

Targeting metalloenzymes for therapeutic intervention

AY Chen, RN Adamek, BL Dick, CV Credille… - Chemical …, 2018 - ACS Publications
Metalloenzymes are central to a wide range of essential biological activities, including
nucleic acid modification, protein degradation, and many others. The role of metalloenzymes …

Molecular docking as a popular tool in drug design, an in silico travel

J De Ruyck, G Brysbaert, R Blossey… - … and Applications in …, 2016 - Taylor & Francis
New molecular modeling approaches, driven by rapidly improving computational platforms,
have allowed many success stories for the use of computer-assisted drug design in the …

Ene‐reductase: a multifaceted biocatalyst in organic synthesis

T Kumar Roy, R Sreedharan, P Ghosh… - … A European Journal, 2022 - Wiley Online Library
Biocatalysis integrate microbiologists, enzymologists, and organic chemists to access the
repertoire of pharmaceutical and agrochemicals with high chemoselectivity, regioselectivity …

Pyridine and pyrimidine derivatives as privileged scaffolds in biologically active agents

MA Chiacchio, D Iannazzo, R Romeo… - Current medicinal …, 2019 - ingentaconnect.com
Pyridine and pyrimidine derivatives have received great interest in recent pharmacological
research, being effective in the treatment of various malignancies, such as myeloid …

Over 40 years of fosmidomycin drug research: a comprehensive review and future opportunities

T Knak, MA Abdullaziz, S Höfmann, LA Alves Avelar… - Pharmaceuticals, 2022 - mdpi.com
To address the continued rise of multi-drug-resistant microorganisms, the development of
novel drugs with new modes of action is urgently required. While humans biosynthesize the …

New structural classes of antimalarials

GK Rathod, M Jain, KK Sharma, S Das, A Basak… - European journal of …, 2022 - Elsevier
Malaria remains a major vector borne disease claiming millions of lives worldwide due to
infections caused by Plasmodium sp. Discovery and development of antimalarial drugs have …

Development of Inhibitors of the 2C-Methyl-d-erythritol 4-Phosphate (MEP) Pathway Enzymes as Potential Anti-Infective Agents

T Masini, AKH Hirsch - Journal of medicinal chemistry, 2014 - ACS Publications
Important pathogens such as Mycobacterium tuberculosis and Plasmodium falciparum, the
causative agents of tuberculosis and malaria, respectively, and plants, utilize the 2 C-methyl …

The multifaceted MEP pathway: Towards new therapeutic perspectives

A Allamand, T Piechowiak, D Lièvremont, M Rohmer… - Molecules, 2023 - mdpi.com
Isoprenoids, a diverse class of natural products, are present in all living organisms. Their two
universal building blocks are synthesized via two independent pathways: the mevalonate …

Plasmodium falciparum: Multidrug resistance

S Rout, RK Mahapatra - Chemical biology & drug design, 2019 - Wiley Online Library
Malaria is the most lethal and debilitating disease caused by the protozoan parasite
Plasmodium worldwide. The most severe forms of disease and the incidence rates of …